We consistently hold the makers of unsafe medical devices accountable.

Zimmer Durom Cup Hip Implant

We protect the interests of those injured by unsafe Zimmer Durom Cup hip implants.

Since 2006, as many as 13,000 Americans have received the Zimmer Durom Cup hip implant. The medical device is primarily used in this country for Total Hip Arthroplasty (THA). In a THA procedure, the surgeon removes the damaged hip joint and replaces it with a hip prosthesis consisting of a ball component and a socket that has an insert or liner. In the case of the Zimmer Durom Cup implant, all components of the device are metal.

Zimmer marketed its Durom hip replacement device for use in younger patients, claiming the metal contact was more durable than a traditional hip implant. In reality, however, the implants were far more likely than most to require revision surgery after a very short time. Zimmer temporarily suspended sales of the hip implant in 2008 after a warning from renowned hip surgeon Dr. Larry Dorr, a former Zimmer consultant and the Director of the Dorr Institute for Arthritis Research and Education. According to Dr. Dorr’s own experience implanting the Zimmer Durom Cup in 165 hips:

  • Ten hips required revision surgery and four more would soon need revision.
  • Failure rate occurred within two years of initial hip replacement.
  • The Durom cups came loose.
  • They lacked adequate fixation.
  • They actually migrated in one instance.

Dr. Dorr also described the painful symptoms experienced by his patients who required revision surgery:

  • Severe pain and stiffness after rising from seated position causing a noticeable limp for several steps.
  • Walking constantly without a smooth gait or with a limp.
  • Sharp pain in the groin when moving from a bent to an upright position.
  • Difficultly walking down stairs.
  • Lack of endurance in walking.
  • Necessity for using a cane to walk outdoors.

A recent study from the University of Wisconsin compared the relative progress one year after surgery of groups of patients receiving different devices for total hip replacement. In that time, while none of the more modern hip implants failed, the Zimmer Durom Cup demonstrated an alarming 11% failure rate. The Durom Cup recipients reported that their pain and discomfort were no better after the hip surgery than before.

Medical evidence suggests that metal-on-metal hip implants can cause the release of tiny metal ions in the body, leading to inflammation and bone loss in the hip region. The metal ions may also damage organs of the body or lead to genetic changes.

How Waters Kraus & Paul can protect your interests

With a national presence and a wealth of experience representing clients injured by dangerous products and unsafe medical devices, Waters Kraus & Paul provides aggressive representation throughout the entire course of litigation. To learn more about legal representation at Waters Kraus & Paul, or to have one of our attorneys review your potential Zimmer Durom Cup hip implant case, email us or call 800.226.9880.

Zimmer Durom Cup Hip Implants:

  • 13,000 Americans received Zimmer hip implants
  • 11% failure rate for Zimmer Durom Cup
  • 2008 year sales temporarily suspended
  • Metal-on-metal hip implants release metal ions
  • Metal ions cause inflammation, bone loss, organ damage, genetic changes

People who require revision surgery may experience:

  • Severe pain / stiffness after rising from seat
  • Sharp groin pain when moving to upright position
  • Noticeable limp for several steps after sitting
  • Unsteady gait or limp is present
  • Lack of endurance in walking
  • Cane is necessary for walking
  • Difficultly descending stairs

United States Settles With South Carolina Hospital for $72.4 Million After $237 Million Judgment

October 22, 2015 On October 4, 2005, whistleblower Dr. Michael K. Drakeford, an orthopedic surgeon, filed a False Claims Act lawsuit against Tuomey Healthcare System for violations of the Stark Laws on behalf of the United States. The government intervened and took over…

Two New Equity Partners Announced

March 1, 2018 Waters Kraus & Paul welcomes the addition of partners Leslie MacLean and Kevin Loew to equity ownership within the firm. Waters Kraus & Paul is pleased to announce the addition of Leslie MacLean and Kevin Loew as equity partners in the firm. As they are both managing partners of the Dallas and Los Angeles offices respectively, “they have certainly earned the right to help lead us moving forward” says Peter Kraus, managing partner of the firm. About Leslie MacLean Ms. MacLean began her practice in 1995 with a focus in complex civil litigation in the areas of product liability and…
Waters Kraus & Paul announce new equity partners Kevin Loew and Leslie MacLean

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880